Ruth Greferath
Plus aucun poste en cours
Profil
Ruth Greferath is the founder of AC Immune SA, founded in 2003, and NormOxys, Inc., founded in 2004.
At NormOxys, Inc., she held the title of Biology Director from 2009 to 2011.
Dr. Greferath earned a doctorate degree from Yeshiva University.
Anciens postes connus de Ruth Greferath
| Sociétés | Poste | Fin |
|---|---|---|
| AC IMMUNE SA | Fondateur | - |
NormOxys, Inc.
 NormOxys, Inc. Pharmaceuticals: MajorHealth Technology NormOxys, Inc. develops small-molecule therapeutics for the treatment of cancer. Its major product is OXY111A. The company was founded by Conrad J Bletzer, Jr. Claude Nicoalu, Jean-Mearie Lehn, Gay Goodman, Ruth Greferath and Roscoe Brady in 2004 and is headquartered in Brighton, MA. | Fondateur | - |
Formation de Ruth Greferath
| Yeshiva University | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AC IMMUNE SA | Health Technology |
| Entreprise privées | 1 |
|---|---|
NormOxys, Inc.
NormOxys, Inc. Pharmaceuticals: MajorHealth Technology NormOxys, Inc. develops small-molecule therapeutics for the treatment of cancer. Its major product is OXY111A. The company was founded by Conrad J Bletzer, Jr. Claude Nicoalu, Jean-Mearie Lehn, Gay Goodman, Ruth Greferath and Roscoe Brady in 2004 and is headquartered in Brighton, MA. | Health Technology |
